Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lorna Allen"'
Autor:
Jane Chudleigh, Pru Holder, Corinna Clark, Louise Moody, Jacqui Cowlard, Lorna Allen, Claire Walter, James R. Bonham, Felicity Boardman
Publikováno v:
SSM: Qualitative Research in Health, Vol 6, Iss , Pp 100455- (2024)
Externí odkaz:
https://doaj.org/article/6bc12c57e0394c7d8c03395afb67a5c0
Autor:
Corinna C. A. Clark, Pru Holder, Felicity K. Boardman, Louise Moody, Jacqui Cowlard, Lorna Allen, Claire Walter, James R. Bonham, Jane Chudleigh
Publikováno v:
International Journal of Neonatal Screening, Vol 10, Iss 2, p 31 (2024)
There is increasing interest in using extended genetic sequencing (EGS) in newborn screening (NBS) for cystic fibrosis (CF). How this is implemented will change the number of children being given an uncertain outcome of CRMS/CFSPID (cystic fibrosis t
Externí odkaz:
https://doaj.org/article/b111c1366dd746a1b0c816dfc1d461f9
Autor:
Lucy Allen, Lorna Allen, Siobhan B. Carr, Gwyneth Davies, Damian Downey, Marie Egan, Julian T. Forton, Robert Gray, Charles Haworth, Alexander Horsley, Alan R. Smyth, Kevin W. Southern, Jane C. Davies
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-13 (2023)
The cystic fibrosis landscape has changed dramatically over the last few decades, with improvements in patient quality of life, prognosis and predicted survival. In part, this is related to the availability of novel CFTR modulator drugs, although pri
Externí odkaz:
https://doaj.org/article/af6dbf378488437ba2ee3bb91e8f2e23
Autor:
Pru Holder, Corinna C. Clark, Louise Moody, Felicity K. Boardman, Jacqui Cowlard, Lorna Allen, Claire Walter, James R. Bonham, Jane Chudleigh
Publikováno v:
International Journal of Neonatal Screening, Vol 10, Iss 1, p 13 (2024)
The project aimed to gather, analyse, and compare the views of stakeholders about the proposed UK cystic fibrosis (CF) screening protocol incorporating next generation sequencing (NGS). The study design was based on principles of Q-methodology with a
Externí odkaz:
https://doaj.org/article/8a840be6573c4e9f9e4b5c2ea5431e7e
Autor:
Michaele Francesco Corbisiero, Nisha Batta, Hannah Kyllo, Anthony Smyth, Lorna Allen, Carlos Franco-Paredes
Publikováno v:
IDCases, Vol 32, Iss , Pp e01784- (2023)
Cutibacterium acnes, previously known as Proprionobacterium, is a commensal Grampositive bacterium of the skin commonly implicated in prosthetic joint infections. However, it has been documented to play a role in other conditions, including SAPHO syn
Externí odkaz:
https://doaj.org/article/eb8d5c0ac2fc49baba6a9f4f2d7a8405
Autor:
Dia Soilemezi, Aileen R. Neilson, Zoe L. Saynor, Naseerah Akooji, Steve Cunningham, Don S. Urquhart, Ioannis Vogiatzis, Emily Taylor, Steff Lewis, Lorna Allen
Publikováno v:
NIHR Open Research, Vol 2 (2022)
Background: Chest physiotherapy is an established cornerstone of care for people with cystic fibrosis (pwCF), but is often burdensome. Guidelines recommend at least one chest physiotherapy session daily, using various airway clearance techniques (ACT
Externí odkaz:
https://doaj.org/article/5a2ef11769fb473b9f56dccd55e1e122
Autor:
Sophie Herbert, Sherie Smith, Katie Gathercole, Christabella Ng, Nicola Rowbotham, Gwyneth Davies, Sarah J Collins, Zoe Elliott, Lorna Allen, Alan Smyth
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Introduction Relieving gastrointestinal (GI) symptoms was identified as a ‘top ten’ priority by our James Lind Alliance Priority Setting Partnership in cystic fibrosis (CF). We conducted an online survey to find out more about the effect of GI sy
Externí odkaz:
https://doaj.org/article/bfa05a56b9fa4e60beb38b3347b63029
Autor:
Misha Huang, Lorna Allen, Kerry Schwarz, Matthew A Miller, Amanda H Howard, Tanner M Johnson, Valida Bajrovic, Kyle C Molina
Publikováno v:
Clin Infect Dis
Background Bezlotoxumab (BEZ) is a monoclonal antibody used to prevent recurrent Clostridioides difficile infection (rCDI). This study investigates BEZ effectiveness in relation to rCDI and patient-specific risk factors in a real-world setting. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46bef30539bc154e3d6813f0aaa68b59
https://doi.org/10.1093/cid/ciab674
https://doi.org/10.1093/cid/ciab674
Autor:
Kyle C Molina, Matthew A Miller, Tanner M Johnson, Misha Huang, Amanda H Howard, Valida Bajrovic, Lorna Allen
Publikováno v:
Open Forum Infectious Diseases. 8
Background Bezlotoxumab significantly reduces the incidence of recurrent Clostridioides difficile infection (CDI); however, limited data are available in solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. Methods We cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0863af05b62f0b03a28fc5d19b9859a8
https://doi.org/10.1093/ofid/ofab294
https://doi.org/10.1093/ofid/ofab294
Publikováno v:
Curr Trop Med Rep
PURPOSE OF REVIEW: Mycobacterial infections may affect any human organ and produce disseminated disease in immunocompromised individuals. Their most common clinical presentations include pulmonary, cutaneous (skin and soft tissues), and disseminated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f08dfc6c627fd6a2caba9356e1eb2ca4
https://doi.org/10.1007/s40475-018-0161-7
https://doi.org/10.1007/s40475-018-0161-7